Stefan Sandström, författare på Biosector Ltd. - Page 2 of 6

Business executive overlooking Japan’s pharmaceutical opportunity, with Mount Fuji, Tokyo skyline, Shinkansen, laboratory scientists, DNA helix, medicine vials, and an upward growth graph.

by Stefan Sandström

Catching Pharmaceutical Opportunities in Japan’s Reinvented Pharmaceutical Arena

For too long, if you ask me, the Japan pharmaceutical market opportunity has been treated as […]

0

Wide Biosector infographic showing five human-relevant model systems in drug discovery: spheroids, organoids, assembloids, organ-on-a-chip, and multi-organ systems, arranged from lower complexity to stronger translational insight.

by Stefan Sandström

Organoids, Organs-on-Chips, and the End of Lazy Translation

This article is a run-through of organoids and organs-on-chips in drug discovery! Drug discovery has a […]

0

Illustration of a company at a crossroads choosing among three market access routes into Japan: Own MAH, 3rd party DMAH, or Japanese partner as MAH, shown as three numbered roads leading toward a Tokyo cityscape.

by Stefan Sandström

MAH, DMAH, or a Japanese Partner: A Strategic Choice You Need to Make Before Entering Japan

Entering Japan is not only about regulatory approval, launch planning, and commercial ambition. One of the […]

0

A side-by-side comparison of a Japanese tradeshow. The left panel, labeled "THEN," is rendered in dull grey-brown tones and shows exhausted, confused professionals wandering a crowded, chaotic expo floor, staring at maps and phones. The right panel, labeled "SOON," is vibrant and modern, showing happy professionals in formal suits and dresses engaging in focused, productive meetings and exchanging business cards in a well-organized, high-signal event space.

by Stefan Sandström

AI-Powered Events: The Future of Data-Driven Connection and High-Signal Events

Let’s be brutally honest: the traditional event experience is fundamentally broken. It is a relic of […]

0

Illustration of the supply chain for targeted alpha therapy in Japan using Astatine-211. The graphic shows domestic cyclotron production, GMP radiochemistry and automated purification, a national site network strategy, time-critical logistics across Japan due to the 7.2-hour half-life, and outpatient administration of the radiopharmaceutical.

by Stefan Sandström

Targeted Alpha Therapy in Japan: why Domestic ²¹¹At Supply Matters for Scale

Radioligand therapy is now a board-level topic in Japan, not because the science is new, but […]

0

by Stefan Sandström

February 17, 2026

No More Shortcuts: A Customer-First Manifesto for Trust, Quality, and Legacy

H&M invented a new kind of shrinkflation, taking the size of male underwear down. L suddenly […]

0

Abstract wide illustration showing Japan drug pricing from listing to post-launch revisions, using blue shapes on a sand background with red trigger markers.

by Stefan Sandström

December 15, 2025

Japan FY2026 Drug Pricing Reform Draft: What Changes at Listing, What Tightens After Launch

On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]

0

Photorealistic scene of a consultant in a Tokyo meeting room connecting a foreign company with Japanese pharma executives.

by Stefan Sandström

December 11, 2025

Why Japanese Targets Like You, Listen to You – and Still You Don’t Succeed

You fly in, you present, you charm the room. Heads nod. The technical team likes your […]

0

Abstract flat illustration of Japanese blockbuster drugs falling off a 2026 PMP price cliff with coloured bars and icons for key therapy areas.

by Stefan Sandström

December 8, 2025

Japan’s FY2026 Drug Price Revision: PMP Return and the End of the Long-Tail Blockbuster

Japan’s pharmaceutical market is about to run a high-stakes experiment in how hard a mature health […]

0

Abstract illustration of Toronto’s biomedical innovation cluster centered on MaRS, research institutes, and startups.

by Stefan Sandström

December 2, 2025

MaRS and Beyond: How Toronto Engineered a Biomedical Growth Engine

Something quietly extraordinary has been happening in the heart of downtown Toronto. Within one of the […]

0